Iambic Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-09-099/9/26 | New | $65,965,000 | $65,965,000 | Debt Only | 06b | SEC linkSEC |
| 2026-04-084/8/26 | New | $27,769,668 | $27,769,668 | Equity Only | 06b | SEC linkSEC |
| 2025-11-2111/21/25 | New | $99,269,270 | $99,269,270 | Equity Only | 06b | SEC linkSEC |
| 2024-06-066/6/24 | Amended | $38,383,040 | $8,524,997 | Equity Only | 06b | SEC linkSEC |
| 2024-05-075/7/24 | Amended | $29,858,043 | $2,983,052 | Equity Only | 06b | SEC linkSEC |
| 2024-04-254/25/24 | New | $26,874,991 | $26,874,991 | Equity Only | 06b | SEC linkSEC |
| 2023-10-1210/12/23 | New | $103,230,763 | $103,230,763 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Jishnu Bhattacharjee | Director |
| Samit Hirawat | Director |
| Neil Josephson | Executive |
| Fred Manby | Director, Executive |
| Thomas Miller | Director, Executive |
| Pete Olson | Executive |
| Evan Rachlin | Director |
| William Rastetter | Director |
| Michael Secora | Executive |
| Shalini Sharp | Director |
| Mary Tagliaferri | Director |
| Tabbert Teng | Executive |
| R. Jacob Vogelstein | Director |
| Kurt Von Emster | Director |
| Chao Zhang | Executive |
Industry: Biotechnology (See others in industry)
Address:
5627 Oberlin Drive, Suite 120
San Diego, CA, 92121
Phone: (619) 330-5499
San Diego, CA, 92121
Phone: (619) 330-5499